85 results
424B7
ESTA
Establishment Labs Holdings Inc
31 Jan 24
Prospectus with selling stockholder info
4:33pm
Implants in October 2010, the majority of our revenue has been generated from sales of our Motiva Implants in cash pay, non-reimbursable, breast … .
Since launching Motiva Implants in October 2010, the majority of our revenue has been generated from sales of our Motiva Implants in cash pay, non
8-K
EX-10.1
ESTA
Establishment Labs Holdings Inc
9 Jan 24
Establishment Labs Announces $50 Million Private Placement and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2023
4:38pm
, to effect the Closing shall terminate as follows:
(i)Upon the mutual written consent of the Company and Investors that agreed to purchase a majority
8-K
EX-10.2
rj0g8 4obc
9 Jan 24
Establishment Labs Announces $50 Million Private Placement and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2023
4:38pm
8-K
EX-4.1
4myd3df1i2
9 Jan 24
Establishment Labs Announces $50 Million Private Placement and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2023
4:38pm
8-K
EX-3.1
5vvkv
31 May 23
Amendments to Articles of Incorporation or Bylaws
4:12pm
8-K
21bhi8r4d47qfhyjac
31 May 23
Amendments to Articles of Incorporation or Bylaws
4:12pm
424B5
pwn 7xe1jti
26 Apr 23
Prospectus supplement for primary offering
4:05pm
424B5
1aj5e7wxl4r17
24 Apr 23
Prospectus supplement for primary offering
4:56pm
S-3ASR
EX-4.1
5cp30pht0unbvbnn0oi7
24 Apr 23
Automatic shelf registration
4:31pm
S-3ASR
EX-4.2
4pmw11aguv4lz8t
24 Apr 23
Automatic shelf registration
4:31pm
S-3ASR
livaw3apn3gb
24 Apr 23
Automatic shelf registration
4:31pm
8-K
EX-10.1
905k eqvrf3me5
2 Dec 22
Departure of Directors or Certain Officers
4:03pm